Christi Shaw named CEO of Kite Pharma, Gilead’s anti-cancer unit

Christi Shaw named CEO of Kite Pharma, Gilead’s anti-cancer unit

Christi Shaw, inspired by her sister’s cancer, named CEO of Kite Pharma, Gilead’s anti-cancer unit

By MATTHEW HERPER

KITE PHARMA

Kite Pharma, a unit of biotechnology giant Gilead, is focused on treatments that genetically engineer patients’ white blood cells to attack cancer.

READ MORE